Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer

Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer

US Patent 8821872 · Granted Sep 2, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2025
Treating non-alcoholic steatohepatitis with cck inhibitors2025
Compositions and methods for preventing tumors and cancer2024
Compositions and methods for inducing humoral and cellular immunities against tu2024
Nanoparticle to target cancer2023
Compositions and methods for inducing humoral and cellular immunities against tu2023
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Nanoparticle to target cancer2022
Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of 2020
Combinatorial therapies for the treatment of neoplasias using the opioid growth 2020
Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A va2019
Compositions and methods for targeting of the surfactant protein A receptor2018